Nolan PB, et al. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–5.
Article
PubMed
PubMed Central
Google Scholar
Wilson PW, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–72.
Article
CAS
PubMed
Google Scholar
Choi HM, Doss HM, Kim KS. Multifaceted physiological roles of adiponectin in inflammation and diseases. Int J Mol Sci. 2020;21(4):1219.
Article
CAS
PubMed Central
Google Scholar
Ruan H, Dong LQ. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol. 2016;8(2):101–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(6):1321.
Article
PubMed Central
CAS
Google Scholar
Krause MP, Milne KJ, Hawke TJ. Adiponectin-consideration for its role in skeletal muscle health. Int J Mol Sci. 2019;20(7):1528.
Article
CAS
PubMed Central
Google Scholar
Schindler M, et al. Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts. Hum Reprod. 2017;32(7):1382–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Argiles JM, et al. Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J Am Med Dir Assoc. 2016;17(9):789–96.
Article
PubMed
Google Scholar
Tyrovolas S, et al. Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study. J Epidemiol Community Health. 2020;74(1):26–31.
Article
PubMed
Google Scholar
Shishikura K, et al. Association between skeletal muscle mass and insulin secretion in patients with type 2 diabetes mellitus. Endocr J. 2014;61(3):281–7.
Article
CAS
PubMed
Google Scholar
Martinez-Huenchullan SF, et al. Skeletal muscle adiponectin induction in obesity and exercise. Metabolism. 2020;102:154008.
Article
CAS
PubMed
Google Scholar
Tanaka Y, et al. Adiponectin promotes muscle regeneration through binding to T-cadherin. Sci Rep. 2019;9(1):16.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Henstridge DC, Febbraio MA. Adiponectin sparks an interest in calcium. Cell Metab. 2010;11(6):447–9.
Article
CAS
PubMed
Google Scholar
Yoon MJ, et al. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 2006;55(9):2562–70.
Article
CAS
PubMed
Google Scholar
Keshvari S, et al. Muscle-specific overexpression of AdipoR1 or AdipoR2 gives rise to common and discrete local effects whilst AdipoR2 promotes additional systemic effects. Sci Rep. 2017;7:41792.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ito R, et al. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle. PLoS ONE. 2018;13(10):e0205645.
Article
PubMed
PubMed Central
CAS
Google Scholar
Nicholson T, et al. The role of adipokines in skeletal muscle inflammation and insulin sensitivity. J Inflamm. 2018;15:9.
Article
CAS
Google Scholar
Safwat Y, et al. Modulation of skeletal muscle performance and SERCA by exercise and adiponectin gene therapy in insulin-resistant rat. DNA Cell Biol. 2013;32(7):378–85.
Article
CAS
PubMed
Google Scholar
Abou-Samra M, et al. Adiponectin and its mimics on skeletal muscle: insulin sensitizers, fat burners, exercise mimickers, muscling pills … or everything together? Int J Mol Sci. 2020;21(7):2620.
Article
CAS
PubMed Central
Google Scholar
Dionyssiotis Y. Sarcopenia in the elderly. Eur Endocrinol. 2019;15(1):13–4.
Article
PubMed
PubMed Central
Google Scholar
Bauer J, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956–61.
Article
PubMed
PubMed Central
Google Scholar
Adachi H, et al. Long-term retrospective observation study to evaluate effects of adiponectin on skeletal muscle in renal transplant recipients. Sci Rep. 2020;10(1):10723.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li CW, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle. 2019;10(3):586–600.
Article
PubMed
PubMed Central
Google Scholar
Sawaguchi T, et al. Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery. PLoS ONE. 2019;14(11):e0225008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakatsuji H, et al. Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. J Neurol. 2017;264(5):839–47.
Article
CAS
PubMed
Google Scholar
Civitarese AE, et al. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab. 2006;4(1):75–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ryu J, et al. APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor. Cell Rep. 2014;7(4):1227–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kitada M, et al. Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function. Front Endocrinol. 2019;10:187.
Article
Google Scholar
Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313–9.
Article
CAS
PubMed
Google Scholar
Ge Y, Yoon MS, Chen J. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). J Biol Chem. 2011;286(41):35675–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab. 2009;296(1):E22-36.
Article
CAS
PubMed
Google Scholar
Jaminon A, et al. The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes. Int J Mol Sci. 2019;20(22):5694.
Article
CAS
PubMed Central
Google Scholar
Lovren F, et al. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol. 2010;299(3):H656–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo R, et al. Adiponectin and its receptors are involved in hypertensive vascular injury. Mol Med Rep. 2018;17(1):209–15.
CAS
PubMed
Google Scholar
Ding M, et al. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol. 2011;31(6):1403–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ding M, et al. Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. J Mol Cell Cardiol. 2012;52(2):474–84.
Article
CAS
PubMed
Google Scholar
Zhang W, et al. Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway. Mol Med Rep. 2015;12(3):4703–7.
Article
CAS
PubMed
Google Scholar
Nour-Eldine W, et al. Adiponectin attenuates angiotensin II-induced vascular smooth muscle cell remodeling through nitric oxide and the RhoA/ROCK pathway. Front Pharmacol. 2016;7:86.
Article
PubMed
PubMed Central
CAS
Google Scholar
Woodcock EA, Matkovich SJ. Cardiomyocytes structure, function and associated pathologies. Int J Biochem Cell Biol. 2005;37(9):1746–51.
Article
CAS
PubMed
Google Scholar
Mouton AJ, et al. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 2020;126(6):789–806.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gariballa S, et al. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord. 2019;19(1):55.
Article
PubMed
PubMed Central
CAS
Google Scholar
Aleidi S, et al. Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm J. 2015;23(3):250–6.
Article
PubMed
Google Scholar
Kim DH, et al. Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension. 2013;62(1):27–32.
Article
CAS
PubMed
Google Scholar
Kou H, et al. Relationship among adiponectin, insulin resistance and atherosclerosis in non-diabetic hypertensive patients and healthy adults. Clin Exp Hypertens. 2018;40(7):656–63.
Article
CAS
PubMed
Google Scholar
Springer J, Anker SD, Doehner W. Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure. Circ Heart Fail. 2010;3(2):181–2.
Article
PubMed
Google Scholar
Lindberg S, et al. Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction. Diabetes Care. 2014;37(11):3003–8.
Article
CAS
PubMed
Google Scholar
Pineiro R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005;579(23):5163–9.
Article
CAS
PubMed
Google Scholar
Nanayakkara G, et al. The cardio-protective signaling and mechanisms of adiponectin. Am J Cardiovasc Dis. 2012;2(4):253–66.
CAS
PubMed
PubMed Central
Google Scholar
Ding G, et al. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol. 2007;43(1):73–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong F, Ren J. Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity. 2009;17(2):262–8.
Article
CAS
PubMed
Google Scholar
Cao T, et al. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS ONE. 2014;9(8):e103793.
Article
PubMed
PubMed Central
CAS
Google Scholar
Niemann B, et al. CTRP9 mediates protective effects in cardiomyocytes via AMPK- and adiponectin receptor-mediated induction of anti-oxidant response. Cells. 2020;9(5):1229.
Article
CAS
PubMed Central
Google Scholar
Amin RH, et al. Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism. Am J Physiol Heart Circ Physiol. 2010;299(3):H690–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lei X, et al. Exenatide reduces cardiomyocyte apoptosis by stimulating adiponectin secretion and activating APPL1-AMPK-PPARalpha axis. Ann Transl Med. 2019;7(14):326.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li Y, et al. Adiponectin upregulates MiR-133a in cardiac hypertrophy through AMPK activation and reduced ERK1/2 phosphorylation. PLoS ONE. 2016;11(2):e0148482.
Article
PubMed
PubMed Central
CAS
Google Scholar
Palanivel R, et al. Adiponectin stimulates Rho-mediated actin cytoskeleton remodeling and glucose uptake via APPL1 in primary cardiomyocytes. Metabolism. 2014;63(10):1363–73.
Article
CAS
PubMed
Google Scholar
Fang X, et al. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab. 2010;299(5):E721–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Potenza MA, et al. Activation of AMPK/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I/R) injury in rats. PLoS ONE. 2019;14(1):e0210654.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holland WL, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011;17(1):55–63.
Article
CAS
PubMed
Google Scholar
Zhu Q, et al. Adiponectin facilitates postconditioning cardioprotection through both AMPK-dependent nuclear and AMPK-independent mitochondrial STAT3 activation. Oxid Med Cell Longev. 2020;2020:4253457.
PubMed
PubMed Central
Google Scholar
Tao L, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation. 2007;115(11):1408–16.
Article
CAS
PubMed
Google Scholar
Cai X, et al. Adiponectin reduces carotid atherosclerotic plaque formation in ApoE−/− mice: roles of oxidative and nitrosative stress and inducible nitric oxide synthase. Mol Med Rep. 2015;11(3):1715–21.
Article
CAS
PubMed
Google Scholar
Maruyama S, et al. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism. J Biol Chem. 2011;286(37):32790–800.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shibata R, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11(10):1096–103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ikeda Y, et al. Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett. 2008;582(7):1147–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rajendran P, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9(10):1057–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011;91(1):327–87.
Article
PubMed
Google Scholar
Heiss EH, Dirsch VM. Regulation of eNOS enzyme activity by posttranslational modification. Curr Pharm Des. 2014;20(22):3503–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. 2018;15(5):292–316.
Article
CAS
PubMed
Google Scholar
Chen Z, et al. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res. 2009;104(4):496–505.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng KK, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes. 2007;56(5):1387–94.
Article
PubMed
Google Scholar
Amour J, et al. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology. 2009;110(2):317–25.
Article
CAS
PubMed
Google Scholar
Xi W, et al. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun. 2005;332(1):200–5.
Article
CAS
PubMed
Google Scholar
Kim JE, et al. Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. J Endocrinol. 2010;207(1):35–44.
Article
CAS
PubMed
Google Scholar
Liu T, et al. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:1–9.
CAS
Google Scholar
Wang X, et al. Adiponectin improves NF-kappaB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids Health Dis. 2016;15:33.
Article
PubMed
PubMed Central
CAS
Google Scholar
Adya R, et al. Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectin-induced angiogenesis. J Vasc Res. 2012;49(6):534–43.
Article
PubMed
Google Scholar
Shah D, Torres C, Bhandari V. Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activation and pulmonary vascular injury. FASEB J. 2019;33(12):13617–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Z, Xu MJ, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol Immunol. 2016;13(3):301–15.
Article
CAS
PubMed
Google Scholar
Gamberi T, et al. Adiponectin signaling pathways in liver diseases. Biomedicines. 2018;6(2):52.
Article
PubMed Central
CAS
Google Scholar
Combs TP, Marliss EB. Adiponectin signaling in the liver. Rev Endocr Metab Disord. 2014;15(2):137–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Foretz M, Viollet B. Regulation of hepatic metabolism by AMPK. J Hepatol. 2011;54(4):827–9.
Article
PubMed
Google Scholar
Zhang X, et al. Unraveling the regulation of hepatic gluconeogenesis. Front Endocrinol. 2018;9:802.
Article
Google Scholar
Lee JM, et al. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner. J Biol Chem. 2010;285(42):32182–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berasi SP, et al. Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase. J Biol Chem. 2006;281(37):27167–77.
Article
CAS
PubMed
Google Scholar
Buechler C, Wanninger J, Neumeier M. Adiponectin receptor binding proteins—recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 2010;584(20):4280–6.
Article
CAS
PubMed
Google Scholar
Awazawa M, et al. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun. 2009;382(1):51–6.
Article
CAS
PubMed
Google Scholar
Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23(5):770–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miller RA, et al. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J Clin Invest. 2011;121(6):2518–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holland WL, et al. Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis. Mol Metab. 2017;6(3):267–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holland WL, et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 2013;17(5):790–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou M, et al. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology. 2008;48(4):1087–96.
Article
CAS
PubMed
Google Scholar
Masaki T, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology. 2004;40(1):177–84.
Article
CAS
PubMed
Google Scholar
Haukeland JW, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167–74.
Article
CAS
PubMed
Google Scholar
Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19(6):802–12.
Article
PubMed
PubMed Central
Google Scholar
Rorsman P, Ashcroft FM. Pancreatic beta-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117–214.
Article
CAS
PubMed
Google Scholar
Kharroubi I, et al. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun. 2003;312(4):1118–22.
Article
CAS
PubMed
Google Scholar
Lee YH, et al. Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism. 2011;60(12):1664–72.
Article
CAS
PubMed
Google Scholar
Wijesekara N, et al. Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem. 2010;285(44):33623–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okamoto M, et al. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia. 2008;51(5):827–35.
Article
CAS
PubMed
Google Scholar
Mahmoodzadeh Sagheb M, et al. The effects of leptin and adiponectin on Pdx1, Foxm1, and PPARgamma transcription in rat islets of langerhans. Hepat Mon. 2013;13(6):e9055.
PubMed
PubMed Central
Google Scholar
Ye R, et al. Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets. Endocrinology. 2015;156(6):2019–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ye R, Scherer PE. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab. 2013;2(3):133–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ye R, et al. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes beta-cell regeneration. Elife. 2014;3:e03851.
Article
PubMed Central
CAS
Google Scholar
Winzell MS, et al. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem Biophys Res Commun. 2004;321(1):154–60.
Article
PubMed
CAS
Google Scholar
Roy B, et al. Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy. Front Physiol. 2016;7:439.
Article
PubMed
PubMed Central
Google Scholar
Basurto L, et al. Adiponectin is associated with low bone mineral density in elderly men. Eur J Endocrinol. 2009;160(2):289–93.
Article
CAS
PubMed
Google Scholar
Jiang X, et al. Effect of intermittent administration of adiponectin on bone regeneration following mandibular osteodistraction in rabbits. J Orthop Res. 2011;29(7):1081–5.
Article
CAS
PubMed
Google Scholar
Oshima K, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun. 2005;331(2):520–6.
Article
CAS
PubMed
Google Scholar
Wu Y, et al. Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am J Physiol Endocrinol Metab. 2014;306(12):E1418–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luo E, et al. Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomater. 2012;8(2):734–43.
Article
CAS
PubMed
Google Scholar
Wang Y, et al. Adiponectin regulates BMSC osteogenic differentiation and osteogenesis through the Wnt/beta-catenin pathway. Sci Rep. 2017;7(1):3652.
Article
PubMed
PubMed Central
CAS
Google Scholar
Huang CY, et al. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J Cell Physiol. 2010;224(2):475–83.
Article
CAS
PubMed
Google Scholar
Lee HW, et al. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells. 2009;27(9):2254–62.
Article
CAS
PubMed
Google Scholar
Yu L, et al. Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes. Stem Cells. 2015;33(1):240–52.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu Y, Vu V, Sweeney G. Examining the potential of developing and implementing use of adiponectin-targeted therapeutics for metabolic and cardiovascular diseases. Front Endocrinol. 2019;10:842.
Article
CAS
Google Scholar
Lindberg S, et al. Adiponectin, type 2 diabetes and cardiovascular risk. Eur J Prev Cardiol. 2015;22(3):276–83.
Article
PubMed
Google Scholar
Kojima S, et al. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis. 2007;194(1):204–13.
Article
CAS
PubMed
Google Scholar
Lindberg S, et al. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure. Eur J Heart Fail. 2014;16(6):633–8.
Article
CAS
PubMed
Google Scholar
Wang Z, et al. The association between serum adiponectin and 3-month outcome after ischemic stroke. Cardiovasc Diabetol. 2019;18(1):105.
Article
PubMed
PubMed Central
CAS
Google Scholar
Savvidou S, et al. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterol. 2009;43(8):765–72.
Article
CAS
PubMed
Google Scholar
Bugianesi E, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005;90(6):3498–504.
Article
CAS
PubMed
Google Scholar
Gad H. Study of plasma adiponectin and insulin resistance in subjects with non-alcoholic fatty liver disease. Arch Gen Intern Med. 2018;2(3):4.
Article
Google Scholar
da Silva TE, et al. Clinical significance of serum adiponectin and resistin levels in liver cirrhosis. Ann Hepatol. 2018;17(2):286–99.
Article
PubMed
CAS
Google Scholar
Song SH, et al. High serum adiponectin as a biomarker of renal dysfunction: results from the KNOW-CKD study. Sci Rep. 2020;10(1):5598.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guebre-Egziabher F, et al. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant. 2005;20(1):129–34.
Article
CAS
PubMed
Google Scholar
Kuo IC, et al. The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease. PLoS ONE. 2019;14(7):e0220158.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cariou B, Charbonnel B, Staels B. Thiazolidinediones and PPARgamma agonists: time for a reassessment. Trends Endocrinol Metab. 2012;23(5):205–15.
Article
CAS
PubMed
Google Scholar
Werner C, et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes. 2007;56(10):2609–15.
Article
CAS
PubMed
Google Scholar
Xu A, et al. Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology. 2009;150(2):625–33.
Article
CAS
PubMed
Google Scholar
Mohammadi A, Gholamhoseinian A, Fallah H. Zataria multiflora increases insulin sensitivity and PPARgamma gene expression in high fructose fed insulin resistant rats. Iran J Basic Med Sci. 2014;17(4):263–70.
PubMed
PubMed Central
Google Scholar
Landrier JF, et al. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Endocrinology. 2009;150(12):5318–25.
Article
CAS
PubMed
Google Scholar
Tsuchida A, et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes. 2005;54(12):3358–70.
Article
CAS
PubMed
Google Scholar
Coletta DK, et al. Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial. Diabetologia. 2009;52(4):723–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo Z, et al. Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats. Cardiovasc Diabetol. 2012;11:94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Metais C, et al. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin. Metabolism. 2008;57(7):946–53.
Article
CAS
PubMed
Google Scholar